Skip to main content
. 2022 Mar 4;9:842873. doi: 10.3389/fcvm.2022.842873

Table 1.

Baseline characteristic of the cohorts.

MIMIC-III cohort (n = 8580) eICU cohort (n = 9749)
Variables Non-AKI (n = 6,216) AKI
(n = 2,364)
P value Non-AKI
(n = 7,837)
AKI (n = 1,912) P value
Demographics and vital signs
Age, years 72.3 ± 13.7 75.0 ± 12.7 <0.001 69.9 ± 13.9 70.5 ± 13.7 0.110
Weight, kg 80.6 ± 22.3 82.6 ± 24.8 <0.001 88.3 ± 29.5 91.7 ± 31.0 <0.001
Temperature, °C 36.8 ± 0.6 36.6 ± 0.7 <0.001 36.8 ± 0.9 36.4 ± 0.6 <0.001
HR, bpm 102.9 ± 21.2 102.1 ± 22.6 0.145 91.4 ± 18.4 92.1 ± 21.0 0.183
MAP, mmHg 75.7 ± 10.5 73.8 ± 10.8 <0.001 82.7 ± 20.2 75.9 ± 21.4 <0.001
UO, mL 1,813 ± 1,171 1,639 ± 1,193 <0.001 1,734 ± 1,539 1,226 ± 1,033 <0.001
Laboratory tests
PaO2, mmHg 169.2 ± 88.7 137.7 ± 74.7 <0.001 119.4 ± 64.9 122.1 ± 72.2 0.112
PaCO2, mmHg 44.5 ± 12.7 44.1 ± 13.4 0.247 45.3 ± 16.5 40.8 ± 16.2 <0.001
WBC, ×109/L 12.2 ± 6.1 12.2 ± 6.5 0.618 11.2 ± 5.6 12.4 ± 6.5 <0.001
RBC, ×1012/L 3.57 ± 0.68 3.55 ± 0.70 0.138 4.00 ± 0.81 3.86 ± 0.89 <0.001
Hematocrit, % 32.0 ± 6.1 31.9 ± 6.1 0.228 36.2 ± 7.1 34.7 ± 7.8 <0.001
Platelet, ×109/L 216.2 ± 100.2 221.9 ± 105.1 0.024 228.4 ± 93.9 217.7 ± 97.7 <0.001
SCr, mg/dL 1.47 ± 1.55 2.04 ± 1.33 <0.001 1.90 ± 2.05 2.76 ± 2.19 <0.001
BUN, mg/dL 28.0 ± 19.9 46.1 ± 26.7 <0.001 31.3 ± 20.3 50.3 ± 29.0 <0.001
CK, U/L 467 ± 900 442 ± 926 0.246 245 ± 266 427 ± 474 <0.001
Lactate, mmol/L 2.21 ± 1.52 2.22 ± 1.62 0.832 2.31 ± 1.47 2.80 ± 2.13 <0.001
Glucose, mg/dL 141.8 ± 44.2 145.8 ± 48.8 <0.001 165.7 ± 89.6 169.3 ± 98.9 0.145
Calcium, mmol/L 2.10 ± 0.21 2.09 ± 0.22 0.542 2.06 ± 0.50 2.04 ± 0.48 0.091

AKI, acute kidney injury; HR, heart rate; MAP, mean aortic pressure; UO, urine output; PaO2, partial arterial oxygen pressure; PaCO2, arterial partial pressure of carbon dioxide; WBC, white blood cell count; RBC, red blood cell count; SCr, Serum creatinine; BUN, blood urine nitrogen; CK, creatine kinase.